Liquid Biopsy Using Methylation Sequencing for Lung Cancer

Clinical trial NCT04253509 · COMPLETED

Trial details

NCT number: NCT04253509
Sponsor: Samsung Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Cancer Diagnoses Disease

Start date: 2020-02-03
Primary completion: 2022-01-31
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.